Clinical studies recruiting near Daphne

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis · NRG Oncology · NCT05624996 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Alliance For Multispecialty Research - Daphne · Amgen · NCT07037433 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Southern Cancer Center · Pfizer · NCT07144280 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Comp
Phase 3 · Research Site · AstraZeneca · NCT07662044 A Single-arm, Open-label Clinical Trial to Evaluate the Effect of SMT04 in Irritable Bowel Syndrome (IBS)
NA · Changi General Hospital · NCT06636513 MYLUNG Consortium Part 3: Observational Study
Phase N/A · Southern Cancer Center, PC · US Oncology Research · NCT05885698 A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Phase 3 · Southern Cancer Center (SCC) ( Site 8000) · Merck Sharp & Dohme LLC · NCT07060807 A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 N
Phase 2/Phase 3 · Southern Cancer Center, P.C. · Eikon Therapeutics · NCT07365319 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Alliance For Multispecialty Research - Daphne · Amgen · NCT07136012 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis · SWOG Cancer Research Network · NCT06616584 BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Phase 2 · Southern Cancer Center · SCRI Development Innovations, LLC · NCT06773910 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis · SWOG Cancer Research Network · NCT03851445 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis · SWOG Cancer Research Network · NCT05642572 A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced No
Phase 3 · Southern Cancer Center Pc · Bristol-Myers Squibb · NCT07361510 A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Phase 1/Phase 2 · Southern Cancer Center, PC · Pfizer · NCT06966453 Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung
Phase 2 · Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis · SWOG Cancer Research Network · NCT06031688 A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combinat
Phase 3 · Research Site · AstraZeneca · NCT06103864 A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, f
Phase 2 · Southern Cancer Center, PC · Janssen Research & Development, LLC · NCT06667076 A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresec
Phase 3 · Southern Cancer Center Pc · Bristol-Myers Squibb · NCT07361497 Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAK
Phase 2 · Southern Cancer Center (SCC) ( Site 8004) · Merck Sharp & Dohme LLC · NCT06788912 A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination W
Phase 3 · Southern Cancer Center, PC · Bristol-Myers Squibb · NCT06646276 A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Particip
Phase 3 · Southern Cancer Center · Hoffmann-La Roche · NCT06065748 Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Phase 3 · AMR Daphne, AL · Vertex Pharmaceuticals Incorporated · NCT06628908 Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTE
Phase 3 · Alliance For Multispecialty Research - Daphne · Amgen · NCT07684235 A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Phase 2 · Southern Cancer Center · Puma Biotechnology, Inc. · NCT06095505 A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High
Phase 3 · Southern Cancer Center, PC · Stemline Therapeutics, Inc. · NCT06492616 Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty
NA · Alabama Orthopedic Sports Medicine & Baldwin County Surgery · Synaptrix, Inc. · NCT07191067 Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Phase 3 · Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis · SWOG Cancer Research Network · NCT06807437

Look up another city

Look up another condition